missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Human Nidogen-1/Entactin Antibody, R&D Systems™

Mouse Monoclonal Antibody has been used in 3 publications
Brand: R&D Systems MAB2570-500
This item is not returnable.
View return policy
Description
Nidogen-1/Entactin Monoclonal specifically detects Nidogen-1/Entactin in Human samples. It is validated for Western Blot, Immunohistochemistry, Immunocytochemistry, ELISA Capture (Matched Antibody Pair).
Specifications
| Nidogen-1/Entactin | |
| Monoclonal | |
| Unconjugated | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
| enactin, Entactin, Entactin-1, NID1, NID-1, NIDentactin, nidogen (enactin), nidogen 1, nidogen-1, Nidogen1 | |
| Mouse | |
| Protein A or G purified from hybridoma culture supernatant | |
| RUO | |
| 4811 | |
| Reconstitute at 0.5 mg/mL in sterile PBS. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
| IgG1 |
| Western Blot, Immunohistochemistry, Immunocytochemistry, ELISA | |
| 302117 | |
| Western Blot 1 ug/mL, Immunohistochemistry 8-25 ug/mL, Immunocytochemistry 8-25 ug/mL, ELISA Capture (Matched Antibody Pair) 2-8 ug/mL | |
| AAH45606.1 | |
| NID1 | |
| Mouse myeloma cell line NS0-derived recombinant human Nidogen-1/Entactin Leu29-Lys1114 (Gln1113Arg) Accession # AAH45606.1 | |
| 500 μg | |
| Primary | |
| Detects human Nidogen-1/Entactin in ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant human Nidogen-2 is observed. | |
| Human | |
| Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction